Title: RST DLMP Grand Rounds - The Future of Cardiac Troponin as a Biomarker of Myocardial Injury - May 21, 2025
Presenter: Ola J. Hammarsten, M.D., Ph.D.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Evaluate an elevated cardiac troponin level in light of its biochemistry and possibility of assay interference
 - Anticipate how the new generation of full-length cardiac troponin assays may change how we evaluate patients with suspected coronary syndromes
 - Challenge current ideas of how cardiac troponin is released
 
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

 Facebook
 X
 LinkedIn
 Forward